Chemically induced aneuploidy in germ cells. Part II of the report of the 2017 IWGT workgroup on assessing the risk of aneugens for carcinogenesis and hereditary diseases.


Journal

Mutation research. Genetic toxicology and environmental mutagenesis
ISSN: 1879-3592
Titre abrégé: Mutat Res Genet Toxicol Environ Mutagen
Pays: Netherlands
ID NLM: 101632149

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 07 12 2018
revised: 01 02 2019
accepted: 20 02 2019
entrez: 12 11 2019
pubmed: 12 11 2019
medline: 3 4 2020
Statut: ppublish

Résumé

As part of the 7th International Workshops on Genotoxicity Testing held in Tokyo, Japan in November 2017, a workgroup of experts reviewed and assessed the risk of aneugens for human health. The present manuscript is one of three manuscripts from the workgroup and reports on the unanimous consensus reached on the evidence for aneugens affecting germ cells, their mechanisms of action and role in hereditary diseases. There are 24 chemicals with strong or sufficient evidence for germ cell aneugenicity providing robust support for the ability of chemicals to induce germ cell aneuploidy. Interference with microtubule dynamics or inhibition of topoisomerase II function are clear characteristics of germ cell aneugens. Although there are mechanisms of chromosome segregation that are unique to germ cells, there is currently no evidence for germ cell-specific aneugens. However, the available data are heavily skewed toward chemicals that are aneugenic in somatic cells. Development of high-throughput screening assays in suitable animal models for exploring additional targets for aneuploidy induction, such as meiosis-specific proteins, and to prioritize chemicals for the potential to be germ cell aneugens is encouraged. Evidence in animal models support that: oocytes are more sensitive than spermatocytes and somatic cells to aneugens; exposure to aneugens leads to aneuploid conceptuses; and, the frequencies of aneuploidy are similar in germ cells and zygotes. Although aneuploidy in germ cells is a significant cause of infertility and pregnancy loss in humans, there is currently limited evidence that aneugens induce hereditary diseases in human populations because the great majority of aneuploid conceptuses die in utero. Overall, the present work underscores the importance of protecting the human population from exposure to chemicals that can induce aneuploidy in germ cells that, in contrast to carcinogenicity, is directly linked to an adverse outcome.

Identifiants

pubmed: 31708072
pii: S1383-5718(18)30443-1
doi: 10.1016/j.mrgentox.2019.02.004
pii:
doi:

Substances chimiques

Aneugens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

403023

Informations de copyright

Crown Copyright © 2019. Published by Elsevier B.V. All rights reserved.

Auteurs

Francesca Pacchierotti (F)

Health Protection Technology Division, Laboratory of Biosafety and Risk Assessment, ENEA, CR Casaccia, Rome, Italy.

Kenichi Masumura (K)

Division of Genetics and Mutagenesis, National Institute of Health Sciences, Kanagawa, Japan.

David A Eastmond (DA)

Department of Molecular, Cell and System Biology, University of California, Riverside, CA, USA.

Azeddine Elhajouji (A)

Novartis Institutes for Biomedical Research, Preclinical Safety, Basel, Switzerland.

Roland Froetschl (R)

BfArM, Bonn, Germany.

Micheline Kirsch-Volders (M)

Laboratory for Cell Genetics, Faculty of Sciences and Bio-Engineering, Vrije Universiteit Brussel, Brussels, Belgium.

Anthony Lynch (A)

GSK, Ware, United Kingdom.

Maik Schuler (M)

Pfizer, Groton, CT, USA.

David Tweats (D)

University of Swansea, Wales, United Kingdom.

Francesco Marchetti (F)

Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON K1A 0K9, Canada. Electronic address: francesco.marchetti@canada.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH